End-of-day quote
Korea S.E.
06:00:00 2024-04-29 pm EDT
|
5-day change
|
1st Jan Change
|
72,400
KRW
|
+1.26%
|
|
+2.40%
|
+1.69%
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Capitalization
1 |
128,489
|
94,604
|
90,059
|
124,993
|
163,965
|
138,724
|
Enterprise Value (EV)
1 |
122,199
|
85,954
|
85,936
|
118,525
|
158,229
|
126,021
|
P/E ratio
|
9.39
x
|
11.8
x
|
6.64
x
|
9.1
x
|
14.6
x
|
8.63
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.85
x
|
0.65
x
|
0.58
x
|
0.78
x
|
0.83
x
|
0.59
x
|
EV / Revenue
|
0.81
x
|
0.59
x
|
0.56
x
|
0.74
x
|
0.8
x
|
0.54
x
|
EV / EBITDA
|
6.66
x
|
6.06
x
|
3.94
x
|
4.51
x
|
6.47
x
|
4.13
x
|
EV / FCF
|
-49
x
|
-27
x
|
-10.1
x
|
275
x
|
-175
x
|
21.4
x
|
FCF Yield
|
-2.04%
|
-3.7%
|
-9.89%
|
0.36%
|
-0.57%
|
4.68%
|
Price to Book
|
1.41
x
|
0.97
x
|
0.88
x
|
1.12
x
|
1.38
x
|
1.06
x
|
Nbr of stocks (in thousands)
|
2,185
|
2,190
|
2,019
|
2,019
|
2,019
|
2,019
|
Reference price
2 |
58,800
|
43,200
|
44,600
|
61,900
|
81,200
|
68,700
|
Announcement Date
|
3/1/18
|
3/1/19
|
2/29/20
|
3/1/21
|
3/1/22
|
3/1/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net sales
1 |
151,063
|
146,485
|
154,724
|
160,234
|
197,470
|
235,166
|
EBITDA
1 |
18,350
|
14,187
|
21,832
|
26,258
|
24,442
|
30,515
|
EBIT
1 |
13,565
|
8,645
|
15,484
|
16,152
|
12,772
|
18,983
|
Operating Margin
|
8.98%
|
5.9%
|
10.01%
|
10.08%
|
6.47%
|
8.07%
|
Earnings before Tax (EBT)
1 |
17,123
|
9,545
|
16,411
|
15,929
|
14,563
|
20,939
|
Net income
1 |
13,579
|
7,370
|
13,507
|
13,777
|
11,350
|
16,261
|
Net margin
|
8.99%
|
5.03%
|
8.73%
|
8.6%
|
5.75%
|
6.91%
|
EPS
2 |
6,265
|
3,675
|
6,719
|
6,806
|
5,571
|
7,959
|
Free Cash Flow
1 |
-2,495
|
-3,182
|
-8,498
|
431.4
|
-903.8
|
5,897
|
FCF margin
|
-1.65%
|
-2.17%
|
-5.49%
|
0.27%
|
-0.46%
|
2.51%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
1.64%
|
-
|
19.33%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
3.13%
|
-
|
36.27%
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/1/18
|
3/1/19
|
2/29/20
|
3/1/21
|
3/1/22
|
3/1/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
6,289
|
8,650
|
4,123
|
6,468
|
5,736
|
12,702
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-2,495
|
-3,182
|
-8,498
|
431
|
-904
|
5,897
|
ROE (net income / shareholders' equity)
|
15.8%
|
8.51%
|
14.1%
|
12.8%
|
9.75%
|
12.9%
|
ROA (Net income/ Total Assets)
|
8.75%
|
5.59%
|
8.92%
|
8.26%
|
6.16%
|
8.42%
|
Assets
1 |
155,271
|
131,957
|
151,336
|
166,762
|
184,262
|
193,044
|
Book Value Per Share
2 |
41,557
|
44,699
|
50,578
|
55,419
|
58,718
|
64,815
|
Cash Flow per Share
2 |
3,616
|
4,530
|
2,600
|
3,756
|
3,228
|
6,331
|
Capex
1 |
16,204
|
13,125
|
25,410
|
15,947
|
5,767
|
17,093
|
Capex / Sales
|
10.73%
|
8.96%
|
16.42%
|
9.95%
|
2.92%
|
7.27%
|
Announcement Date
|
3/1/18
|
3/1/19
|
2/29/20
|
3/1/21
|
3/1/22
|
3/1/23
|
|
1st Jan change
|
Capi.
|
---|
| +1.69% | 106M | | +1.20% | 67.6B | | +44.29% | 40.33B | | +15.99% | 38.65B | | +4.67% | 32.55B | | +6.59% | 18.94B | | +12.32% | 16.76B | | +17.69% | 15.07B | | +8.31% | 14.83B | | -14.74% | 13.79B |
Other Commodity Chemicals
|